These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29707162)

  • 1. Correction: Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells.
    Zhu XX; Yan YW; Chen D; Ai CZ; Lu X; Xu SS; Jiang S; Zhong GS; Chen DB; Jiang YZ
    Oncotarget; 2018 Apr; 9(25):17978. PubMed ID: 29707162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells.
    Zhu XX; Yan YW; Chen D; Ai CZ; Lu X; Xu SS; Jiang S; Zhong GS; Chen DB; Jiang YZ
    Oncotarget; 2016 Sep; 7(39):63561-63570. PubMed ID: 27566578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2019 Aug; 10(50):5253. PubMed ID: 31497254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.
    Brodie S; Lee HK; Jiang W; Cazacu S; Xiang C; Poisson LM; Datta I; Kalkanis S; Ginsberg D; Brodie C
    Oncotarget; 2021 Dec; 12(26):2546-2547. PubMed ID: 34966487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.
    Tian X; Ma J; Wang T; Tian J; Zhang Y; Mao L; Xu H; Wang S
    Front Immunol; 2019; 10():2929. PubMed ID: 32038606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
    Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
    Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height.
    Tatton-Brown K; Hanks S; Ruark E; Zachariou A; Del Vecchio Duarte S; Ramsay E; Snape K; Murray A; Perdeaux ER; Seal S; Loveday C; Banka S; Clericuzio C; Flinter F; Magee A; McConnell V; Patton M; Raith W; Rankin J; Splitt M; Strenger V; Taylor C; Wheeler P; Temple IK; Cole T; ; Douglas J; Rahman N
    Oncotarget; 2018 Nov; 9(94):36719. PubMed ID: 30613354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Kupffer cells-dependent inflammation in the injured liver increases recruitment of mesenchymal stem cells in aging mice.
    Yang X; Liang L; Zong C; Lai F; Zhu P; Liu Y; Jiang J; Yang Y; Gao L; Ye F; Zhao Q; Li R; Han Z; Wei L
    Oncotarget; 2020 Oct; 11(42):3805-3806. PubMed ID: 33144922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Long non-coding RNAs could act as vectors for paternal heredity of high fat diet-induced obesity.
    An T; Zhang T; Teng F; Zuo JC; Pan YY; Liu YF; Miao JN; Gu YJ; Yu N; Zhao DD; Mo FF; Gao SH; Jiang G
    Oncotarget; 2019 Jan; 10(7):798. PubMed ID: 30774781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients.
    Wang D; Lu P; Zhang H; Luo M; Zhang X; Wei X; Gao J; Zhao Z; Liu C
    Oncotarget; 2021 May; 12(10):1024-1025. PubMed ID: 34012514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis.
    Jing H; Liao L; An Y; Su X; Liu S; Shuai Y; Zhang X; Jin Y
    Mol Ther; 2016 Feb; 24(2):217-229. PubMed ID: 26307668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
    Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
    Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.
    Hemming S; Cakouros D; Vandyke K; Davis MJ; Zannettino AC; Gronthos S
    Stem Cells Dev; 2016 Jun; 25(12):909-21. PubMed ID: 27168161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
    Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
    Oncotarget; 2018 Aug; 9(60):31787. PubMed ID: 30167094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Non-invasive
    Peng BY; Chiou CS; Dubey NK; Yu SH; Deng YH; Tsai FC; Chiang HS; Shieh YH; Chen WH; Deng WP
    Oncotarget; 2018 May; 9(38):25383. PubMed ID: 29863193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.
    Lin CY; Hsieh PL; Liao YW; Peng CY; Lu MY; Yang CH; Yu CC; Liu CM
    Oncotarget; 2018 May; 9(37):24870. PubMed ID: 29873328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells.
    Steinbichler TB; Abdelmoez A; Metzler VM; Dejaco D; Riechelmann H; Dudas J; Skvortsova II
    Oncotarget; 2019 Oct; 10(56):5889. PubMed ID: 31645908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition.
    Wei X; Li Q; Li Y; Duan W; Huang C; Zheng X; Sun L; Luo J; Wang D; Zhang S; Xin X; Gao M
    Oncotarget; 2022; 13():118-119. PubMed ID: 35035777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.
    Gordian E; Welsh EA; Gimbrone N; Siegel EM; Shibata D; Creelan BC; Cress WD; Eschrich SA; Haura EB; Muñoz-Antonia T
    Oncotarget; 2021 Jun; 12(13):1325. PubMed ID: 34194632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.